NDC 75987-130 – Tepezza
Teprotumumab 500 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC75987-130
Product details
- Brand name
- Tepezza
- Generic name
- teprotumumab
- Labeler
- Horizon Therapeutics USA, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761143
- Marketed since
- January 21, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Insulin-like Growth Factor-1 Receptor Inhibitor
Active ingredients
- Teprotumumab 500 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 75987-130-15 | 1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE | Jan 21, 2020 |